Pacira BioSciences (PCRX) Prepaid Assets (2010 - 2026)

Pacira BioSciences' Prepaid Assets history runs 17 years deep, the most recent figure standing at $36.8 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 32.11% year-over-year to $36.8 million in Q1 2026; TTM through Mar 2026 was $36.8 million, a 32.11% increase from a year earlier, with the FY2025 full-year figure at $32.6 million, up 48.74% from the prior year.
• Prepaid Assets improved to $36.8 million in Q1 2026 per PCRX's latest filing, from $32.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $43.5 million in Q3 2025 and bottomed at $14.4 million in Q3 2022.
• The 5-year median for Prepaid Assets is $19.8 million (2024), against an average of $23.7 million.
• Across the five-year window, Prepaid Assets slipped 16.4% in 2023 and soared 88.25% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $15.2 million in 2022, then jumped by 41.26% to $21.5 million in 2023, then grew by 1.98% to $21.9 million in 2024, then soared by 48.74% to $32.6 million in 2025, then advanced by 12.75% to $36.8 million in 2026.
• Per Business Quant, the three latest PCRX Prepaid Assets figures stand at $36.8 million (Q1 2026), $32.6 million (Q4 2025), and $43.5 million (Q3 2025).